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Abstract
Background: A recent qualitative study in Denmark showed that genital warts (GWs) can considerably lower the
quality of life of heterosexual patients. In this follow-up study, we interviewed men having sex with men (MSM)
suffering from GWs to obtain an in-depth understanding of their perception of GWs and determine the extent to
which minority (homosexual) cultural issues affect these patients’ experiences. Qualitative interviews with six MSM
were performed using a semi-structured interview guide. Questions were formulated on the basis of the earlier
qualitative study in heterosexual patients with GWs along with a literature review. Data were analysed using a
medical anthropological approach.
Findings: Many MSM worried about being stigmatised and excluded from the small homosexual ’scene’, their key
social group, thereby lowering their chances of finding sex and love. Most participants had suffered from GWs for
several years which added to the negative psycho-sexual and social effects of the disease. Participants’ fears of
developing anal cancer were similar to those expressed about cervical cancer by females with GWs.
Conclusions: Ano-genital human papillomavirus (HPV) infection is common and has a serious psychological and
sexual impact among MSM. However, they do not benefit to the same extent as heterosexual men from the herd
immunity effect of HPV vaccination of girls. The pathological profile and concerns specific to MSM should be
addressed when communicating with these patients, and should be taken into account when considering HPV
vaccination of boys.
Background
Genital warts (GWs), one of the most common sexually
transmitted diseases (STD), can significantly lower
patients’ quality of life (QoL). A qualitative study carried
out among young heterosexual Danes [1] showed that
patients with GWs worried about the uncertain timeline
and perspectives of recovery, and that they were often
depressed and had low self esteem. The patients’ self-
image as well as their social lives were affected by the stig-
matisation caused by the disease. Patients found it difficult
to detach themselves from their GWs because of the
repeated treatments, the social manoeuvres required to
conceal the disease and the negative effects on their love
and sex lives, in particular [1]. These results are in line
with published data pointing to a substantial need for
more knowledge about GWs and improved doctor-patient
communication [2-16].
Fifteen articles (in English) on the effects of GWs on
the QoL of patients of both sexes were identified from a
literature search using PubMed, Embase, Cinahl and Psy-
cinfo [2-16]. Four of the studies focused on the effects of
human papillomavirus (HPV) infection in men [4-7].
A review of the articles showed that the effects of having
GWs on QoL were similar for men and women. How-
ever, women tended to worry more about their fertility,
infecting a baby during childbirth and the development
of cervical cancer for those who knew about HPV [8,9].
One study revealed that men more frequently reacted
with denial, delayed seeking treatment and worried about
pain [6]. Only one study focused on men having sex with
men (MSM) and their knowledge of HPV [4].
Approximately 90% of GWs are caused by infection with
HPV types 6 and 11 [17]. The quadrivalent HPV vaccine
that was introduced in the Danish childhood immunisa-
tion programme in October 2008 contains HPV 6 and 11
virus-like particles as well HPV type 16 and 18 virus-like
particles (high-risk HPV types). In Denmark, this vaccine
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12-year-old girls with a catch-up programme for 13-15
year-old girls. A herd immunity effect on heterosexual
men is expected, but such effects for MSM would be
expected to be more limited [18].
GWs in MSM are often located in the intra- or peria-
nal region, and it has been reported that anal warts are
t w i c ea sf r e q u e n ta sG W si nt h is population [19]. Like
the cervical tract, the anal canal has a transformation
zone between the columnar epithelium of the rectum
and the squamous epithelium of the anus, which is
more receptive to HPV infection than the mucosa and
skin of the rest of the ano-genital region [20]. The treat-
ment of intra-anal warts is often protracted and painful,
and recurrence rates are high. The impact of treatment
on the risk of HPV transmission is uncertain [21,22].
HPV infection is highly prevalent in men and even
more so in the case of MSM [23-28]. In one study, HPV
DNA was found in the anal canal in 57% of HIV-negative
MSM, with 26% having high-risk HPV types and 26%
having low-risk HPV types; co-infection is frequent [29].
Anal infection with multiple HPV types is associated
with receptive anal intercourse and the number of
sex partners [29,30]. High-risk HPV types are found in
almost all anal cancers in homosexual men, suggesting
that HPV infection is prerequisite for the development of
these cancers [31,32]. Although anal HPV infections are
frequent, anal cancers are still relatively rare in Denmark
(0.5 per 100 000 person-years) suggesting that unidenti-
fied factors influence the progression from HPV infection
to cancer. Nonetheless, incidence rates of anal cancer
have increased over the last half century, and incidence
rates among MSM are high compared with that of the
general population. It is estimated that the prevalence of
anal cancer among MSM is currently at least as high as
the prevalence of cervical cancer before the introduction
of cervical screening programmes [29]. Incidence rates
are particularly high among HIV-positive MSM, in spite
of treatment with HAART (highly active antiretroviral
therapy) [32,33].
Despite the fact that MSM have a higher risk than
heterosexual men of contracting GWs, are less likely to
benefit from the herd immunity effect of the vaccination
programme, and are more likely to develop anal cancer,
very little data are available on GWs in MSM. The
objective of the present study, the first of its kind in
MSM, was to examine in depth the way GWs may affect
the QoL in this population and if particular minority
cultural issues were relevant to their experiences with
this disease.
Methods
The previous study of heterosexual patients with GWs
was based on two qualitative group interviews with a
total of ten participants, five women and five men [1].
Qualitative research methods are considered the most
appropriate for examining patients’ perceptions of a dis-
ease [34,35]. In the present follow-up study, we initially
planned to carry out a similar group interview with five
or six MSM, however, patients were too reluctant to dis-
cuss the subject in a group. Hence we conducted indivi-
dual interviews and sought to determine the reasons for
their reluctance with a semi-structured question guide
(Table 1), developed using a previously-described
approach [1].
The six participants were recruited from the Venereal
Diseases Clinic at the Bispebjerg Hospital in Copenha-
gen, Denmark, and through homosexual media. Patients
were eligible if they had suffered from GWs for at least
three months and had no serious co-morbidity or other
STDs. Patients who fulfilled the inclusion criteria were
informed orally at the clinic about the study by the con-
sulting physician, who also gave them a study informa-
tion sheet. Patients willing to participate contacted one
o ft h ea u t h o r s ,G L M ,w h oa c t e da sa ni n d e p e n d e n t
researcher. The study did not require ethics committee
approval in Denmark and all participants gave written
informed consent. No personal information about the
participants was collected or communicated from the
Venereal Diseases Clinic to the authors or other people
involved in the study. The participants’ anonymity was
ensured throughout the study.
Interviews were conducted by GLM in small conference
rooms at a hotel or in the participants’ homes, according
to their preference. The purpose of the study (to obtain
comprehensive knowledge about MSM patients’ experi-
ences with and perceptions of GWs) was explained.
Patients were interviewed using a semi- and funnel-
structured interview guide (Table 1), beginning with
questions about the participant’s perception of GWs: the
causes, its management and timeline. Questions then
focused on the personal consequences of having GWs,
including the effects on the patients’ self-esteem, social
and love life. Participants were asked about the reasons for
their reluctance to participate in a group interview. Ques-
tions were open-ended to ensure an exploratory approach
and capture as many perspectives as possible [36,37].
Interviews were transcribed verbatim and analysed using
a discourse analytical approach to the relations between
language and socio-cultural construction of meaning [38].
After coding and classifying data into the main patterns of
meaning, a comparative analysis was carried out identify-
ing how the QoL of MSM was affected by having GWs
and how this differed from heterosexual patients with
GWs. All methodological and analytical steps were dis-
cussed and alternative interpretations sought with an inde-
pendent anthropologist. Disagreements were solved using
Spradley’s process of resolution of qualitative data [37].
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Six patients, aged between 31 and 59 years participated,
and all but one were single. Four participants had intra-
anal GWs, five had perianal GWs and one had penile
GWs. One participant had had perianal GWs for only
three months. The other participants had had GWs for
3 to 10 years, some with periods of remission (Table 2).
The perception of GWs among MSM
The participants considered GWs as a repulsive and
stigmatising STD that they did not know much about
before they themselves were affected. All patients con-
sidered that treatment options were limited in terms of
effectiveness, duration and prevention of recurrence,
and had underestimated the effects of the disease on
their psycho-sexual and social QoL. MSM felt frustrated
throughout the course of treatment and had a strong
need for information about HPV infections and treat-
ment options - including the effects of the HPV vaccine
which two participants had already received with the
hope of increasing the efficacy of their GW treatment.
In particular, participants said they had substantial
needs for information about the relation between GWs
and anal cancer, with several expressing worry about the
risk of developing anal cancer. In addition to the psy-
cho-sexual and social consequences of GWs, fear of




Opening Introduction of the
participant
What is your name, age and how long have you been suffering from GWs?
Introductory
question
Participant’s reaction to the
GWs diagnosis
1. How did you react when you heard that you had GWs?
Transitional
question
Perception of illness 2. What are your views on this disease (in comparison to other STDs, for instance)?
Cues: Cause, consequences, treatment options, time to cure and knowledge about HPV
3. Does the fact that it is caused by HPV influence your views on the disease?
Key questions Effects of GWs on QoL 4. How has your life been affected by having GWs?
a. Physical effects
b. The course of treatment
Cues: Pain, embarrassment, worries about treatment effectiveness, duration and, knowledge, doctor-
patient communication, practical aspects
c. Effects on work and studies
Cues: Concerns about stigma, ability to work/study, sick leave, contagion, social avoidance
d. Social relations
Cues: Concerns about stigma, contagion, avoidance, social isolation
e. We initially wanted to base this study on a group interview, but the MSM we talked to were very
reluctant to participate in this and would only participate in an individual interview. Could you
explain why this might be?
f. Love life
Cues: Worries about present or future partners, infidelity, contagion, conflicts about infidelity or disrupted
sex life, fear of rejection and disapproval
g. Sex life
Cues: Desire/lust, initiative, pleasure, spontaneity, avoidance, low self esteem, negative body perception,
fear of rejection, lack of sexual ability
h. Psychological effects
Cues: Guilt, shame, anger, worries about the future, depression, fear, negative self perception, identity,
insecurity, disease phobia
5. Has your quality of life changed since you were first diagnosed with GWs, and if yes, how?
Closing
questions
6. Do you feel you have sufficient knowledge about GWs?
7. Is there anything you think we ought to have discussed but did not?
GWs, genital warts
Table 2 Participant characteristics
Age (years) Marital status Years since first occurrence of GWs Recurrences GW location
1 31 Single 3-4 Several (maximum 2 month clearances) Anal and perianal
2 33 Single 8 Several (short periods of clearance) Anal and perianal
3 47 Single 9-10 4 Penile and anal
4 31 Single 4-5 1 (1-1.5 year clearance) Anal
5 51 Single 4-5 3 (maximum 2-3 month clearances) Perianal
6 59 Married (same sex) 8 None Perianal
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GWs. These concerns were highly dependent on their
doctors’ communication and the information they pro-
vided about the disease.
“When I read that, I thought ‘Oh, my God!’. I had no
idea what it was all about! I don’t understand whether
it’s infectious when you just touch each other (anywhere)
or if the virus is only local. I don’t think that’s clear from
the information provided. But I could read - and that’s
when I got all worked up - that anal cancer and God
knows what can develop!"(31-year-old MSM)
GWs in the social context
The participants in this study feared the potential
impact that GWs could have on their status in the social
group to which many felt a strong sense of belonging.
Several participants described the homosexual scene as
t h ep l a c ew h e r et h e yf i t t e di na n dw h e r et h e yw e r e
accepted for who they are. Commonly, the scene was
both the primary social framework for the participants
and the starting point for finding a steady or occasional
partner. At the same time, the scene w a sd e p i c t e da sa
‘village’ where gossip was widespread, and bullying and
victimisation were not uncommon. As one participant
put it:
“If you are heterosexual, the problem of GWs mainly
involves your relationship with your partner, but if you
are gay, you also worry about rumours spreading in a
minority culture where everybody knows each other and
a negative reputation creates barriers to meeting other
men and to being accepted.” (59-year-old MSM)
The participants in this study frequently compared
GWs with HIV. For instance, some said that while GWs
were not as serious as HIV, having GWs corresponded
to being HIV-positive in its social and sexual conse-
quences. Some said they considered GWs to be more
serious because using condoms does not entirely protect
against HPV infection, or that GWs had a more restric-
tive influence on their sex and love life because they
were potentially visible.
“I just know that if I tell anyone, it will be passed on to
the others. The rumour will spread and I’ll simply be
excluded. I’ll be branded. I feel branded. I can draw so
many parallels to someone who’s HIV-positive. That’s
why I can understand someone who’s HIV-positive who
won’t disclose his status when he is with someone. I can’t
blame them. It’s like HIV ‘you don’tg e ti n f e c t e d ,y o ul e t
yourself be infected’.I t ’s the same thing with the GWs,
well, I let myself be infected, and it’s my own fault! I
know it’s not possible to protect yourself 100% from GWs
but that thought is stuck at the back of my head.... Of
course, it’s not that GWs are more serious than HIV, not
at all, but I understand someone saying that because it
is very visible (this participant had penile GWs),i t ’sv e r y
inhibiting and you can’t do anything about it. Someone
who’s HIV-positive can just use a condom and practise
safe sex. That’s not b***** possible with GWs!”
GLM: “What exactly do you mean by being branded?”
“Well, you might as well deport me to a deserted
island. That’s how I feel. Because nobody will want any-
t h i n gt od ow i t hy o ua ta l l .Y o u ’ll be a walking infected
abscess and nobody wants to having anything to do with
you” (47-year-old MSM)
According to the participants, fear of rejection was the
reason given for not wanting to participate in a group
interview where there would be a risk of meeting others
from the scene. One participant had become so sexually
insecure after developing GWs that he had entirely with-
drawn from the scene and thus also its broader social
advantages. Another participant had lost his confidence
in relationships with other people in general. Participants
whose GWs or scarring were visible to potential sexual
partners seemed to have experienced the most negative
affects on their social lives. They said they feared a sexual
and social exclusion from the scene because their condi-
tion would be talked about and this increased the nega-
tive psychological effects of the disease.
The effects of GWs on participants’ sex and love lives
According to some participants, the reluctance to parti-
cipate in a group interview was ultimately about the risk
of not finding sex and love:
“You’re exposed to so many external stressful issues -
including the society, the family, that homosexuality is
not accepted, lack of rights... all those things: girls that
you may have dated at the beginning and with whom it
didn’t work out. It would be weird if you didn’tr e a c tb y
becoming sensitive. That’sw h yi t ’sas m a l ls c e n ew i t ha
lot of sensitive people. So the reason that you can’tt a l k
about it (GWs) in a group interview is related to two
things: that it’s a small scene and that people are sensitive
-they are sensitive about being rejected again. Essentially,
it’s all about love. When people won’tp a r t i c i p a t e ,i t ’s
because they’re afraid of not experiencing love because of
what will be said in the scene. Because, when I meet peo-
ple - that applies to one-night-stands or if I’ve been at the
park - it applies to everybody: what people really want is
to be cared for. They want to be loved. It’sq u i t es i m p l e ,
actually. But because they’ve had one downfall after
another, bad experiences, families not recognising them,
they don’t know how love works. They don’tk n o wh o wt o
r e c e i v el o v e .A n dt h e nq u i c k l y ,y o u ’ll be sorted out. It’s
also a scene where you can’t have children. It goes fast, if
things don’t just work, you move on!” (31-year-old MSM)
The location of the GWs and the participants’ prefer-
ences for receptive or insertive anal sex had an important
impact on whether they had any sexual encounters. The
decisive factor was whether the GWs or the scarring
Lee Mortensen and Larsen BMC Research Notes 2010, 3:280
http://www.biomedcentral.com/1756-0500/3/280
Page 4 of 7were visible to the sexual partner and whether the GWs
influenced the possibilities of having a sex life. The two
participants who had perianal GWs and who no longer
practiced receptive anal sex did not have to reveal their
GWs, so they could still have sex.
For the other participants, their sex lives were ruined
due to fear of infecting others, worries about pain, about
disclosure and rejection. Several participants had
stopped even trying to find a partner or to have sex,
thus reducing their chances of developing a steady rela-
tionship from a casual sexual contact. One participant,
who still had some occasional sexual encounters, was so
preoccupied with hiding the disease during intercourse
that it often turned out to be tense and awkward. Most
participants had stopped looking for a steady relation-
ship because they were scared about having to reveal
their disease. Some had been in relationships that ended
because of the devastating effects of the GWs on their
sex life. With one exception, all the participants said
that having GWs had an extremely negative impact on
their sex and love lives.
The physical and psychological effects of having GWs
The main physical effects of having GWs were related to
treatment which often caused pain, soreness and ulcera-
tions. For one participant, prolonged treatment had
ruined his ano-genital mucous membranes as well as his
anal sphincter. He could not have sex or bowel move-
ments without pain and bleeding. Another participant
had stopped treatment for long periods because treat-
ment was much worse than the symptoms of the GWs.
T h em o r et h ep a r t i c i p a n t s ’ sex and love lives were
affected by the GWs, the worse the negative impact on
their psychological well-being. In particular, the partici-
pants whose sex and love lives had come to a standstill
described themselves as being socially and sexually inse-
cure and as loathing their own bodies. Just like hetero-
sexual patients with GWs, the participants worried
about the development of their GWs, were often
depressed and frustrated with the disease and felt alone
in their suffering.
Three participants had had nervous breakdowns which
they attributed, to varying degrees, to their GWs, and for
which they had subsequently received psychological
treatment. According to these participants the disease
had ruined their self-esteem and made them feel like
‘unclean infected disease carriers’. One 33-year-old parti-
cipant who had had GWs for eight years felt that he
would have been a different person without this disease
which had affected him profoundly during his formative
years.
“I recently finished my studies, but they [GWs] affect
my work life just as they did my studies. It’s still as if I
don’t rise to the occasion. I’m tied up. If I was free from
them [GWs], I think I’d also feel freer in my relation-
ships with others, that I could stand by myself and do
things more whole-heartedly. I don’t really dare to stand
out or be noticed. That’s due to the GWs, I think. I feel
like people think that I’m not really present. That affects
people and makes them uncertain of me. I don’ts h o w
myself and they can feel that there is something wrong.
It’s hard because I am not 100% there, because I’m still
‘disconnected’ from here (points to his chest) downwards.
Id o n ’t think you can be entirely present if your body is
not with you... I’ve got like two jobs but they’ve got noth-
ing to do with my career. I kind of dread that a bit.
I finished studying five months ago and got straight A’s
so that’sg o o d .B u ti t ’sl i k eId o n ’td a r et og oo u tt h e r e
and sell myself and that’s what I have to do in my line
of business. You have to sell yourself and I can’t do that”
(33-year-old MSM).
Discussion
This study, based on interviews with a small number of
participants, is the first to use qualitative methodology
to examine in depth the disease experiences of MSM
with GWs. Qualitative research methodology allows for
an analytical, but not a statistical generalisation of
results. This is both a strength and a limitation. In
many respects, the results of this study are very similar
to those of our study in heterosexual patients with GWs
[ 1 ]a sw e l la st h o s ei d e n t i f i ed in the literature [3-17].
While this validates the results from the present study,
we also identified information about the perspectives of
MSM with GWs which need to be confirmed in a larger
study.
The method of recruitment may have introduced a
selection bias because patients with more negative dis-
ease experiences may be more likely to volunteer to par-
ticipate in this type of study. Nonetheless, we considered
participants to be representative of Danish MSM with
GWs in terms of the severity of their symptoms, while
the social mechanisms of inclusion and exclusion within
the homosexual minority culture appear similar to those
described in a recent American study in HIV-positive
MSM [39].
The significance of any disease is acquired in the con-
text of a particular socio-cultural framework [35]. In the
c a s eo fG W si nM S Mi no u rs t u d y ,t h i si n c l u d e sa
broader Western concept of STDs and homosexuality,
the Danish society and the homosexual scene as a self-
defined minority culture. Our results showed that
belonging to a homosexual minority group seems to
have significant consequences for MSM who have GWs.
Two social exclusion mechanisms may reinforce each
other when MSM have GWs: in addition to feeling mar-
ginalized as a homosexual in a predominantly heterosex-
ual (external) society, MSM fear stigmatisation internally
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their experience of GWs with that of being HIV posi-
tive, although this is generally considered to be a far
more serious disease. This association was explained by
the psycho-sexual and social consequences of having
GWs, which the participants put on the same footing
as the experiences of homosexual men who are HIV-
positive. The US study in MSM showed that stigmatisa-
tion of men who were HIV positive in the homosexual
scene led to worry, loneliness, depression and avoidance
strategies [39]. In addition, these participants had had
GWs for a longer period of time than the heterosexuals
in the previous study and this added to the negative psy-
chological consequences for them.
Most of the participants in this study said that rejec-
tion from the homosexual scene would mean a loss of
belonging to their significant social group and reduced
chances of finding sex and love. Having GWs thus not
only affected the participants’ sex life, it could also have
far-reaching social and psychological consequences. Self-
stigmatization, anticipatory stigma and actual experience
of stigma or discrimination were thus closely interre-
lated and worked together in shaping these participants
experiences with GWs. In addition, their treatment was
frequently painful, with a timeframe which was mostly
longer than for the heterosexual participants in the pre-
vious study [1].
This study showed that, just like women with GWs
fearing the development of cervical cancer when they
learnt about HPV, MSM also worried about anal cancer
when they were aware of HPV. Both heterosexual and
homosexual patients felt that GWs were not considered
to be as serious as other potentially fatal STDs by health
care professionals and that this lead to a gap between
health care professionals perspective and their own wor-
ries about GWs. These participants wanted a better
understanding of the issues and questions that patients
with GWs face. Knowledge about specific minority cul-
tural aspects, including the needs of MSM for clear oral
and written information about HPV and anal cancer,
should guide patient communication with MSM.
Conclusions
The prevalence of anal and multiple HPV type infec-
tions among MSM are relatively high [23]. Preliminary
data from a randomised clinical trial in men have shown
that quadrivalent HPV vaccination is efficacious in pre-
venting HPV infection and related diseases in men
[40,41]. In a recent review of studies assessing the
acceptance of male HPV vaccination, it was reported
that the acceptability of HPV vaccination was high
among men informed about the direct benefits for men
and when they received doctors’ recommendations
[42-44]. It is important that MSM are well informed
about all aspects of GWs, with the aim of alleviating
both the psychological distress associated with the dis-
ease and to optimise preventive efforts and safe sexual
behaviour.
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